PT Darya-Varia Laboratoria TbkISX:DVLA 74 Gross Margin % is 50.67% as of Mar. 2026, which is 5% below its 10-year median of 53.12. GuruFocus rates ISX:DVLA with a GF Score™ of 74/100 and a GF Value™ of Rp1,842.51 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 935 Drug Manufacturers companies, PT Darya-Varia Laboratoria Tbk ranks better than 57.22% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PT Darya-Varia Laboratoria Tbk had a gross margin of 50.67% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PT Darya-Varia Laboratoria Tbk Gross Margin % Related Terms
PT Darya-Varia Laboratoria Tbk Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:DVLA vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Darya-Varia Laboratoria Tbk Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Gross Margin % of 50.67% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. This is near median its historical median of 53.12. Over the past decade, PT Darya-Varia Laboratoria Tbk's Gross Margin % has ranged from 50.94 to 56.74. According to the industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #400 out of 935 companies in the Drug Manufacturers industry, placing it in the top 42.8%.
Is PT Darya-Varia Laboratoria Tbk's Gross Margin % too high?
PT Darya-Varia Laboratoria Tbk's current Gross Margin % of 50.67% is near median its 10-year median of 53.12. Over the past 10 years, this metric has ranged from a low of 50.94 to a high of 56.74. The Drug Manufacturers industry median Gross Margin % is 48.46. PT Darya-Varia Laboratoria Tbk's value of 50.67% is 4.6% above this industry median. Based on the distribution chart, PT Darya-Varia Laboratoria Tbk ranks #400 out of 935 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #400 out of 935 companies for Gross Margin %. This puts PT Darya-Varia Laboratoria Tbk in the upper half of its industry. The industry median Gross Margin % is 48.46. PT Darya-Varia Laboratoria Tbk's value of 50.67% is 4.6% above this benchmark. Historically, PT Darya-Varia Laboratoria Tbk's own Gross Margin % has ranged from 50.94 to 56.74 over the past decade. While the company's 10-year median is 53.12 vs. the industry median of 48.46, PT Darya-Varia Laboratoria Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.46, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Darya-Varia Laboratoria Tbk's current Gross Margin % of 50.67% is 4.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Darya-Varia Laboratoria Tbk's current Gross Margin % is 50.67%, which is near median its own 10-year median of 53.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,842.51, compared to a current price of Rp1,510.00 — trading 18% below its estimated fair value. The current Gross Margin % is 50.67%, which is near median its 10-year median of 53.12 and 4.6% above the Drug Manufacturers industry median of 48.46. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Gross Margin % is 50.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued.
The current stock price of Rp1,510.00 is trading 18% below its estimated GF Value™ of Rp1,842.51.
GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.
Key valuation signals for ISX:DVLA:
Gross Margin %: 50.67% (near median its 10-year median of 53.12)
GF Value™: Rp1,842.51 vs. price of Rp1,510.00 (18% below fair value)
Industry Position: 4.6% above the Drug Manufacturers median (#400 of 935)
No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Darya-Varia Laboratoria Tbk Business Description
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
74GF Score
Get the complete analysis for ISX:DVLA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:DVLA has been successfully added to your 
